Equivalent osteopenia in HIV-infected individuals studied before and during the era of highly active antiretroviral therapy

AIDS

Volumn 15, Issue 2, 2001, Pages 278-280

  Lawal, A ^a   Engelson, E S ^a   Wang, J ^a   Heymsfield, S B ^a   Kotler, D P ^a  

^a Teachers College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CALCITRIOL; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; OSTEOCALCIN; OXANDROLONE; PARATHYROID HORMONE; PROTEINASE INHIBITOR; RECOMBINANT GROWTH HORMONE; STEROID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D;

ARTICLE; BONE DENSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; OSTEOPENIA; PATHOGENESIS; PRIORITY JOURNAL;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BONE DENSITY; BONE DISEASES, METABOLIC; FEMALE; HIV INFECTIONS; HUMANS; MALE; TIME FACTORS;

EID: 0035951450     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200101260-00022     Document Type: Article

References (21)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. Update trends in AIDS incidence - United States, 1996
3. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors
4. The Australian Lipodystrophy Prevalence Survey
5. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy
6. Osteopenia in a randomized, multicenter study of protease inhibitor (PI) substitution in patients with the lipodystrophy syndrome and well-controlled HIV viremia
7. Bone mineral density in patients with human immunodeficiency virus infection
8. Measuring body fat in patients with the acquired immunodeficiency syndrome: Which method should be used?
9. Symptomatic osteoporosis in two young HIV-positive African women
10. Subnormal serum concentration of 1,25 dihydroxyvitamin D3 in HIV infection: Correlation with degree of immunodeficiency and survival
11. Disseminated Mycobacterium avium complex in AIDS: Immunopathogenic significance of an activated tumor necrosis factor system and depressed serum levels of 1,25 dihydroxyvitamin D
12. Severe deficiency of 1,25 dihydroxy vitamin D3 in HIV-infection - Association with immunological hyperactivity and only minor changes in calcium homeostasis
13. Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: Contribution to the development of human immunodeficiency virus associated lipodystrophy syndrome
14. Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: Indication of normalization of the bone-remodelling process during highly active antiretroviral therapy
15. A possible role for cortisol/anticortisol imbalance in the progression of HIV
16. NF-κ B and bone: The breaking point
17. Pathogenesis of HIV infection
18. HIV cultured from bone. Implications for transplantation
19. Loss of lean body mass and muscle mass correlates with androgen levels in hypogonadal men with HIV and wasting
20. Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with HIV
21. Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two day fast in normal men